Key facts
- Exonicus’s last known valuation is $11.5M (May 2025).
- It has raised $830K; the latest was Equity Crowdfunding ($1.1M) in May 2025.
- Notable investors include Capital Factory, Startup Wise Guys, ASP Asset Management, Alesco Ventures, Horizon 2020 — 8 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 8 names
- ·Watchlist + deal alerts for Exonicus
- ·The full record, as it builds
Funding rounds
No funding rounds for Exonicus are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Exonicus
Developer of extended reality (XR) medical training technology designed to create immersive trauma simulations crucial for military and civilian medical professionals. The company develops medical simulators that enable medical personnel to augment their trauma treatment capabilities, allowing physicians to address medical training challenges with the aid of technological advancements, enhance medical preparedness, and improve patient outcomes in critical care scenarios.
- Sector
- Information Technology
- HQ
- Seattle, WA, United States
- Employees
- 5
- Website
- exonicus.com/
- Ownership
- Privately Held (backing)
Exonicus doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Exonicus shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Exonicus in its N-PORT filings yet. We sweep new filings monthly.